miR-223: Sailing to terra incognita for microRNAs in platelets

Thrombosis and Haemostasis

Volumn 110, Issue 6, 2013, Pages 1112-1113

  Halkein, Julie ^a   De Windt, Leon J ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBOCYTIC AGENT; MICRORNA 223;

ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR SYSTEM; ENDOTHELIUM CELL; GENE EXPRESSION; GENE EXPRESSION REGULATION; HEART INFARCTION; HUMAN; MEGAKARYOCYTE; POSTTRANSCRIPTIONAL GENE SILENCING; PRIORITY JOURNAL; SCIENTIST; THROMBOCYTE ACTIVATION; THROMBOCYTE FUNCTION; THROMBOCYTOPOIESIS;

ANIMALS; BLOOD PLATELETS; CELL-DERIVED MICROPARTICLES; DIABETES MELLITUS, TYPE 2; ENDOTHELIAL CELLS; GENE EXPRESSION REGULATION; HUMANS; MICE; MICE, KNOCKOUT; MICRORNAS; MYOCARDIAL INFARCTION; PLATELET ACTIVATION; RISK; THROMBOPOIESIS;

EID: 84888420821     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH13-10-0882     Document Type: Article

References (6)

1. Leiderseider S, et al MiR-223 is dispensable for platelet production and function in mice. Thromb Haemost 2013; 110: 1207-1214.
2. Willeit P, et al. Circulating microRNAs as novel biomarkers for platelet activation. Circulation Res 2013; 112: 595-600.
3. Laffont B, et al. Activated platelets can deliver mRNA regulatory Ago2*microRNA complexes to endothelial cells via microparticles. Blood 2013; 122: 253-261.
4. Felli N, et al. MicroRNA 223-dependent expression of LMO2 regulates normal erythropoiesis. Haematologica 2009; 94: 479-486.
5. Yuan JY, et al. MicroRNA-223 reversibly regulates erythroid and megakaryocytic differentiation of K562 cells. J Cell Mol Med 2009; 13: 4551-4559.
6. Zampetaki A, et al. Prospective study on circulating MicroRNAs and risk of myocardial infarction. J Am Coll Cardiol 2012; 60: 290-299.